bèta
Trial Radar AI
De klinische studie NCT07235254 voor Chronische wond, Hard to Heal Wounds, Dressing, Wondgenezing, Wondgenezing is nog niet rekruterend. Bekijk de kaartweergave van de Klinische Studies Radar en de AI-ontdekkingstools voor alle details. Of stel hier een vraag.
Eén studie komt overeen met de filtercriteria
Kaartweergave
Terug naar zoekresultaten

A RCT of Moist Ag Dressing in Chronic Wound

Nog niet rekruterend
Informatie over klinische studies is voornamelijk in het Engels beschikbaar. Trial Radar AI kan echter helpen! Klik op 'Leg studie uit' om de informatie over de studie te bekijken en te bespreken in de taal van uw keuze.
De klinische studie NCT07235254 is een interventioneel studie bij Chronische wond, Hard to Heal Wounds, Dressing, Wondgenezing, Wondgenezing met de status nog niet rekruterend. De inclusie van 40 deelnemers start op 1 december 2025. De studie wordt geleid door Peking University Third Hospital en de voltooiing is gepland op 1 september 2027. Laatste update op ClinicalTrials.gov: 19 november 2025.
Beknopte samenvatting
This study aims to explore the differences in efficacy and cost-effectiveness between self-adhesive soft polysilicone silver ion foam dressings and traditional silver dressings in local infected wounds through a prospective randomized controlled study. The goal is to provide evidence-based medical support for clinical application, further shorten the wound healing time, and reduce the economic burden on the medical system and patients.
Officiële titel

Dry Versus Moist Ag Dressings for Local Wound Infections: A Randomized Controlled Trial on Effectiveness and Cost-Effectiveness

Aandoeningen
Chronische wondHard to Heal WoundsDressingWondgenezingWondgenezing
Andere studie-ID's
  • Long2025-CW-Ag foam dressing
NCT-ID
NCT07235254
Startdatum (Werkelijk)
2025-12-01
Laatste update geplaatst
2025-11-19
Verwachte einddatum
2027-09-01
Inschrijving (Geschat)
40
Studietype
Interventioneel
FASE
N.v.t.
Status
Nog niet rekruterend
Primaire doel
Behandeling
Toewijzing
Gerandomiseerd
Interventiemodel
Parallel
Blindering
Enkelblind
Armen / Interventies
Deelnemersgroep/StudiearmInterventie/Behandeling
ExperimenteelMOIST Ag dressing
Using MepilexAg in conjunction with conventional clinical treatments
Ag Foam Dressing Named Mepilexag
Using MepilexAg in conjunction with conventional clinical treatments in chronic local infectious ulcer
Actieve comparatorDry Ag dressing
Using dry Ag dressing in conjunction with conventional clinical treatments
DRY Ag Dressing
Using dry Ag dressing in conjunction with conventional clinical treatments
Primaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
wound area reduction in two weeks
Pre-treatment area minus post-treatment area, then divided by pre-treatment area
From enrollment to the end of treatment at 2 weeks
Secundaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
wound healing rate
Percentage of healed wounds to total cases by D14
From enrollment to the end of treatment at 2 weeks
Geschiktheidscriteria

Leeftijd van deelnemers
Volwassene, Oudere volwassene
Minimumleeftijd
18 Years
Geslachten die in aanmerking komen voor de studie
Allen
  1. The patient's age ranges from 18 to 80 years old.
  2. According to the IWII wound infection staging, infected wounds are classified as local infections*.
  3. The wound type is ulcer, with an ulcer area ranging from 1 to 40 cm².
  4. The wound stage is in the necrosis stabilization phase, granulation growth phase, or epithelial crawling phase**.
  5. Voluntary participation in this study and signing the informed consent form

  1. Severe diseases such as acute myocardial infarction, heart failure, hepatitis, shock, and respiratory failure have not been corrected yet;
  2. The blood sugar level of diabetes is out of control, with fasting blood sugar > 15 mmol/L and glycosylated hemoglobin ≥ 10%;
  3. There is active bleeding in the wound, and the conventional basic treatment plan cannot be implemented;
  4. Serum albumin < 20 g/L; hemoglobin < 60 g/L; platelets < 50 × 109/L;
  5. Disseminated infection or systemic infection state, and antibiotics are being used or will be used for treatment;
  6. Patients with advanced malignant tumors;
  7. The patient is in the active stage of autoimmune diseases;
  8. The patient has previously been allergic to self-adhesive soft polysilicone silver ion foam dressings (Meipikang Silver) or Anxidean Nano Silver Trauma Patch;
  9. The patient cannot cooperate or has a mental disorder;
  10. According to the investigator's judgment, the subject has clear reasons that affect wound healing and is not suitable for this study or cannot comply with the requirements of this study.
Peking University Third Hospital logoPeking University Third Hospital
Verantwoordelijke instantie
Long Zhang, Hoofdonderzoeker, Head of Wound Healing Center, Peking University Third Hospital
Centraal Contactpersoon
Contact: Long Zhang Executive Deputy Director, Medical Doctor, +86 010-82266699, [email protected]
1 Studielocaties in 1 landen

Beijing Municipality

Peking University Third Hospital, Beijing, Beijing Municipality, 100191, China
Yunfeng Li, Medical Doctor, Contact, +86 010-82267791, [email protected]